$0.06
61.46% day before yesterday
Nasdaq, Dec 27, 09:57 pm CET
ISIN
US67011T2015
Symbol
NVOS

Novo Integrated Sciences Inc Stock price

$0.05
+0.01 18.86% 1M
-1.45 96.51% 6M
-1.45 96.51% YTD
-1.45 96.51% 1Y
-14.35 99.64% 3Y
-49.95 99.90% 5Y
-39.95 99.87% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
+0.02 40.97%
ISIN
US67011T2015
Symbol
NVOS
Sector

Key metrics

Market capitalization $880.00k
Enterprise Value $5.74m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.43
P/S ratio (TTM) P/S ratio 0.07
P/B ratio (TTM) P/B ratio 0.07
Revenue growth (TTM) Revenue growth 5.75%
Revenue (TTM) Revenue $13.29m
EBIT (operating result TTM) EBIT $-8.31m
Free Cash Flow (TTM) Free Cash Flow $-5.07m
Cash position $840.00k
EPS (TTM) EPS $-0.91
Short interest 1.57%
Show more

Is Novo Integrated Sciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Financial data from Novo Integrated Sciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
13 13
6% 6%
100%
- Direct Costs 7.55 7.55
17% 17%
57%
5.74 5.74
66% 66%
43%
- Selling and Administrative Expenses 12 12
30% 30%
89%
- Research and Development Expense - -
-
-
-6.05 -6.05
7% 7%
-46%
- Depreciation and Amortization 2.26 2.26
23% 23%
17%
EBIT (Operating Income) EBIT -8.31 -8.31
3% 3%
-63%
Net Profit -16 -16
22% 22%
-122%

In millions USD.

Don't miss a Thing! We will send you all news about Novo Integrated Sciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Novo Integrated Sciences Inc Stock News

Neutral
Business Wire
10 days ago
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports 2024 Fiscal Year Financial Results.
Neutral
Business Wire
5 months ago
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results.
Neutral
Business Wire
5 months ago
BELLEVUE, Wash.--(BUSINESS WIRE)---- $NVOS #AAPI--Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program.
More Novo Integrated Sciences Inc News

Company Profile

Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.

Head office United States
CEO Robert Mattacchione
Employees 264
Founded 2000
Website novointegrated.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today